Indegene

Indegene Intangible Assets

The Intangible Assets of Indegene (INDGN.NS) as of Oct 22, 2026 is 1.86 B INR. In the previous year, Intangible Assets was 1.98 B INR — a change of -6.15% (lower).

Intangible Assets

1.86 BINR

YoY

-6.15%

Last updated:

Intangible Assets of Indegene is 2025 1.86 B INR. Intangible Assets of Indegene was 2024 1.98 B INR. It decreases by -6.15% lower compared to the previous year.

The Indegene Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2022
169.49 M INR
Jan 1, 2023
1.92 B INR
Jan 1, 2024
1.98 B INR
Jan 1, 2025
1.86 B INR
The Indegene Intangible Assets history
YEARIntangible AssetsYoY
1.86 BINR-6.15%
1.98 BINR+3.11%
1.92 BINR+1,035.24%
169.49 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd generates revenue by providing digital-led commercialization services to life sciences companies, including biopharmaceutical, emerging biotech, and medical devices firms. The company assists these clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and the sales and marketing of their products. This comprehensive support structure allows Indegene to serve as a key partner in the end-to-end commercialization process for its diverse client base within the life sciences sector. The company monetizes its offerings through specialized solution segments such as Omnichannel Activation, which helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Additionally, Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations, further expanding the company's service portfolio and revenue streams. Revenue is also derived from Enterprise Medical Solutions, where Indegene establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The company rounds out its business model by offering enterprise clinical solutions and consultancy services, ensuring a holistic service delivery model that addresses various operational needs of its customers in the life sciences industry. Indegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indegene stock

Intangible Assets of Indegene is 1.86 B INR in 2025.

Intangible Assets of Indegene changed from 1.98 B INR to 1.86 B INR, representing a -6.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Indegene since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Indegene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Indegene

All Key Metrics — Indegene